IBM Retirement Fund’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-697
Closed -$231K 496
2022
Q1
$231K Sell
697
-42
-6% -$12.9K 0.03% 471
2021
Q4
$265K Sell
739
-514
-41% -$174K 0.03% 466
2021
Q3
$408K Hold
1,253
0.03% 476
2021
Q2
$391K Sell
1,253
-257
-17% -$78.8K 0.03% 496
2021
Q1
$481K Sell
1,510
-125
-8% -$40K 0.03% 462
2020
Q4
$530K Buy
1,635
+196
+14% +$54.2K 0.04% 430
2020
Q3
$399K Buy
1,439
+404
+39% +$116K 0.03% 428
2020
Q2
$250K Buy
+1,035
New +$208K 0.03% 455
2019
Q1
Sell
-640
Closed -$208K 412
2018
Q4
$208K Sell
640
-56
-8% -$19.5K 0.05% 350
2018
Q3
$313K Sell
696
-113
-14% -$44.5K 0.07% 306
2018
Q2
$331K Sell
809
-96
-11% -$34.8K 0.07% 322
2018
Q1
$263K Buy
+905
New +$229K 0.05% 417
2017
Q1
Sell
-3,165
Closed -$357K 787
2016
Q4
$357K Sell
3,165
-570
-15% -$66K 0.02% 719
2016
Q3
$480K Sell
3,735
-274
-7% -$32.8K 0.02% 650
2016
Q2
$438K Buy
+4,009
New +$399K 0.02% 714

Other funds holding ABMD

IBM Retirement Fund's ABMD Position: Q2 2022 in Review

IBM Retirement Fund sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 697 shares — an estimated $231K sold.

IBM Retirement Fund first reported a position in ABMD in Q2 2016 and held it in 15 quarters. The position peaked at $530K in Q4 2020. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

  • IBM Retirement Fund reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
  • IBM Retirement Fund sold 697 Abiomed Inc shares in Q2 2022, an estimated $231K.
  • IBM Retirement Fund first reported a position in Abiomed Inc in Q2 2016 and held it in 15 quarters.
  • IBM Retirement Fund's Abiomed Inc position peaked at $530K in Q4 2020.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on IBM Retirement Fund's 13F filing for Q2 2022, filed 20 Jul 2022.